Related references
Note: Only part of the references are listed.Safety of 6000 intravitreal dexamethasone implants
Bindu Rajesh et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2020)
Rhegmatogenous Retinal Detachment after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor
Philip P. Storey et al.
OPHTHALMOLOGY (2019)
The Impact of Prefilled Syringes on Endophthalmitis Following Intravitreal Injection of Ranibizumab
Philip P. Storey et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2019)
PPV, Retinectomy, and Silicone Oil Without Scleral Buckle for Recurrent RRD From Proliferative Vitreoretinopathy
Jordan D. Deaner et al.
OPHTHALMIC SURGERY LASERS & IMAGING RETINA (2019)
Reductions in final visual acuity occur even within the first 3 days after a macula-off retinal detachment
Margaret A. Greven et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2019)
OUTCOMES OF REPEAT PARS PLANA VITRECTOMY AFTER FAILED SURGERY FOR PROLIFERATIVE VITREORETINOPATHY
Ramsudha Narala et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2018)
Five-year visual acuity outcomes and injection patterns in patients with pro-re-nata treatments for AMD, DME, RVO and myopic CNV
Thomas Wecker et al.
BRITISH JOURNAL OF OPHTHALMOLOGY (2017)
Real world outcomes of ocriplasmin use by members of the British and Eire Association of Vitreoretinal Surgeons
R. J. Haynes et al.
EYE (2017)
Negative Results Matter: Why Can't We Improve the Treatment of Proliferative Vitreoretinopathy?
John T. Thompson
OPHTHALMOLOGY (2017)
Slow-Release Dexamethasone in Proliferative Vitreoretinopathy
Philip J. Banerjee et al.
OPHTHALMOLOGY (2017)
Trends in Vitreoretinal Procedures for Medicare Beneficiaries, 2000 to 2014
Michael D. McLaughlin et al.
OPHTHALMOLOGY (2017)
Postinjection Endophthalmitis Rates and Characteristics Following Intravitreal Bevacizumab, Ranibizumab, and Aflibercept
Nadim Rayess et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2016)
Intravitreal Aflibercept for Diabetic Macular Edema 148-Week Results from the VISTA and VIVID Studies
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2016)
Characterization of Anatomic and Visual Function Outcomes in Patients With Full-Thickness Macular Hole in Ocriplasmin Phase 3 Trials
Pravin U. Dugel et al.
AMERICAN JOURNAL OF OPHTHALMOLOGY (2015)
Dexamethasone implant as an effective treatment option for macular edema due to Irvine-Gass syndrome
Wolfgang J. Mayer et al.
JOURNAL OF CATARACT AND REFRACTIVE SURGERY (2015)
Efficacy of Intravitreal Ocriplasmin for Treatment of Vitreomacular Adhesion
Julia A. Haller et al.
OPHTHALMOLOGY (2015)
SAFETY PROFILE OF OCRIPLASMIN FOR SYMPTOMATIC VITREOMACULAR ADHESION A Comprehensive Analysis of Premarketing and Postmarketing Experiences
Paul Hahn et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2015)
Morphology and Function over a One-Year Follow Up Period after Intravitreal Dexamethasone Implant (Ozurdex) in Patients with Diabetic Macular Edema
Rodolfo Mastropasqua et al.
PLOS ONE (2015)
Intravitreal Aflibercept Injection for Macular Edema Due to Central Retinal Vein Occlusion
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2014)
Adverse events and complications associated with intravitreal injection of anti-VEGF agents: a review of literature
K. Ghasemi Falavarjani et al.
EYE (2013)
Enzymatic Vitreolysis with Ocriplasmin for Vitreomacular Traction and Macular Holes
Peter Stalmans et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Intravitreal Aflibercept (VEGF Trap-Eye) in Wet Age-related Macular Degeneration
Jeffrey S. Heier et al.
OPHTHALMOLOGY (2012)
PHARMACOLOGIC VITREOLYSIS
Arnd Gandorfer
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2012)
Incidence of rhegmatogenous retinal detachments after intravitreal antivascular endothelial factor injections
Carsten H. Meyer et al.
ACTA OPHTHALMOLOGICA (2011)
Dexamethasone Intravitreal Implant for Noninfectious Intermediate or Posterior Uveitis
Careen Lowder et al.
ARCHIVES OF OPHTHALMOLOGY (2011)
Ranibizumab and Bevacizumab for Neovascular Age-Related Macular Degeneration The CATT Research Group
Daniel F. Martin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Outcomes and Risk Factors Associated with Endophthalmitis after Intravitreal Injection of Anti-Vascular Endothelial Growth Factor Agents
Chirag P. Shah et al.
OPHTHALMOLOGY (2011)
Dexamethasone Intravitreal Implant in Patients with Macular Edema Related to Branch or Central Retinal Vein Occlusion
Julia A. Haller et al.
OPHTHALMOLOGY (2011)
Randomized Trial Evaluating Ranibizumab Plus Prompt or Deferred Laser or Triamcinolone Plus Prompt Laser for Diabetic Macular Edema
Michael J. Elman et al.
OPHTHALMOLOGY (2010)
A protocol for the retina surgeon's safe initial intravitreal injections
Ronald E. P. Frenkel et al.
CLINICAL OPHTHALMOLOGY (2010)
Intravitreal bevacizumab (avastin) for central and hemicentral retinal vein occlusions - IBeVO study
Rogerio A. Costa et al.
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES (2007)
Ranibizumab for neovascular age-related macular degeneration
Philip J. Rosenfeld et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Share Paper
